Financial Transparency

Transparency, accountability and independence

The International Gaucher Alliance is committed to transparency, accountability and maintaining its independence as a patient-led organisation.

We want our community, members, partners and supporters to understand how the IGA is funded and how our resources support our work for people affected by Gaucher disease around the world.

Our funding at a glance

2025 income : £299,486

IGA receives funding from a range of sources to support its programmes, projects and activities. Corporate organisations can provide support through unrestricted grants or funding for specific projects.

How our resources are used

2025 expenditure : £238,600

The 2025 Impact Report identifies project costs as including project management, administration and professional fees. 

IGA uses its resources to deliver programmes, projects and activities that support the global Gaucher community, alongside the operational costs required to run the organisation responsibly.

Maintaining our independence

IGA works constructively with organisations that support our work while maintaining its independence as a patient-led organisation.

35% funding principle

IGA will only accept unrestricted grants up to an amount not exceeding 35% of its annual budget from any one pharmaceutical company.This principle is stated in the IGA's existing funding information and recent Impact Reports.

Editorial independence

IGA's website is operated independently, and its funders have no editorial control over its contents.

Our latest funding information

See where our support comes from
We publish information about our funding so that our community can understand where financial support for the IGA comes from.

Planning for the future

Responsible financial planning
IGA maintains financial reserves as part of responsible financial planning. This helps protect the continuity of our work and our ability to serve the global Gaucher community.The IGA's previous Impact Reports describe its reserves policy in these terms.

Our financial and funding policies

Our policies help guide how the IGA accepts financial support and works with commercial organisations.

Ethical Statement for Donations

Our approach to accepting donations and financial support.

Code of Practice

Our Code of Practice sets out principles for the IGA's relationships with pharmaceutical companies, including written agreements and transparency around financial and non-financial support.

Financial information

For those who want to look at the underlying financial information, the IGA publishes its financial and impact reporting documents.

2025 Impact Report

A detailed overview of the IGA's work and financial highlights for 2025.

Previous reports